The level of susceptibility to tuberculosis (TB) infection depends upon allelic variations in numerous interacting genes. In our mouse model system, the whole-genome quantitative trait loci (QTLs) scan revealed three QTLs involved in TB control on chromosomes 3, 9, and in the vicinity of the H2 complex on chromosome 17. For the present study, we have established a panel of new congenic, MHC-recombinant mouse strains bearing differential small segments of chromosome 17 transferred from the TB-susceptible I/St (H2j) strain onto the genetic background of TB-resistant C57BL/6 (B6) mice (H2b). This allowed narrowing the QTL interval to 17Ch: 33, 77–34, 34 Mb, containing 36 protein-encoding genes. Cloning and sequencing of the H2j allelic variants of these genes demonstrated profound polymorphic variations compare to the H2b haplotype. In two recombinant strains, B6.I-249.1.15.100 and B6.I-249.1.15.139, recombination breakpoints occurred in different sites of the H2-Aβ 1 gene (beta-chain of the Class II heterodimer H2-A), providing polymorphic variations in the domain β1 of the Aβ-chain. These variations were sufficient to produce different TB-relevant phenotypes: the more susceptible B6.I-249.1.15.100 strain demonstrated shorter survival time, more rapid body weight loss, higher mycobacterial loads in the lungs and more severe lung histopathology compared to the more resistant B6.I-249.1.15.139 strain. CD4+ T cells recognized mycobacterial antigens exclusively in the context of the H2-A Class II molecule, and the level of IFN-γ-producing CD4+ T cells in the lungs was significantly higher in the resistant strain. Thus, we directly demonstrated for the first time that the classical H2- Ab1 Class II gene is involved in TB control. Molecular modeling of the H2-Aj product predicts that amino acid (AA) substitutions in the Aβ-chain modify the motif of the peptide–MHC binding groove. Moreover, unique AA substitutions in both α- and β-chains of the H2-Aj molecule might affect its interactions with the T-cell receptor (TCR).
References
[1]
WHO. Global tuberculosis report 2014. Geneva: World Health Organization. 2014;
[2]
Dye C. Global epidemiology of tuberculosis. Lancet. 2006; 367: 938–940. pmid:16546542 doi: 10.1016/s0140-6736(06)68384-0
[3]
Abdallah AM, van Pittius NC, Champion PA, Cox J, Luirink J, Vandenbroucke-Grauls CM, et al. Type VII secretion–mycobacteria show the way. Nat Rev Microbiol. 2007; 5: 883–891. pmid:17922044 doi: 10.1038/nrmicro1773
[4]
Manzanillo PS, Shiloh MU, Portnoy DA, Cox JS. Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. Cell Host Microbe. 2012;11: 469–480. doi: 10.1016/j.chom.2012.03.007. pmid:22607800
[5]
Sorensen TI, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med. 1988;318: 727–32. pmid:3347221 doi: 10.1056/nejm198803243181202
[6]
Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respi Dis. 1978;117: 621–4.
[7]
Harvald H, Hauge M. Hereditary factors elucidated by twin studies. In: Neel JV, Shaw MW, Schull WL, editors. Genetics and the epidemiology of chronic diseases Washington; 1965. pp61–p76.
[8]
Kallmann FJ, Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberc. 1943;47: 549–574.
[9]
Thye T, Vannberg FO, Wong SH, Owusu-Dabo E, Osei I, Gyapong J, et al. Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11.2. Nat Genet. 2010; 42: 739–741. doi: 10.1038/ng.639. pmid:20694014
[10]
Thye T, Owusu-Dabo E, Vannberg FO, van Crevel R, Curtis J, Sahiratmadja E, et al. Common variants at 11p13 are associated with susceptibility to tuberculosis. Nat Genet. 2012; 44: 257–259. doi: 10.1038/ng.1080. pmid:22306650
[11]
Chimusa ER, Zaitlen N, Daya M, Moller M, van Helden PD, Mulder NJ, et al. Genome-wide association study of ancestry-specific TB risk in the South African Coloured population. Hum Mol Genet. 2013;23: 796–809. doi: 10.1093/hmg/ddt462. pmid:24057671
[12]
Mahasirimongkol S, Yanai H, Mushiroda T, Promphittayarat W, Wattanapokayakit S, Phromjai J, et al. Genome-wide association studies of tuberculosis in Asians identify distinct at-risk locus for young tuberculosis. J Hum Genet. 2012; 57(6): 363–367. doi: 10.1038/jhg.2012.35. pmid:22551897
[13]
M？ller M, Nebel A, Valentonyte R, van Helden PD, Schreiber S, Hoal EG. Investigation of chromosome 17 candidate genes in susceptibility to TB in a South African population. Tuberculosis (Edinb). 2009;89: 189–94. doi: 10.1016/j.tube.2008.10.001
[14]
Rossouw M, Nel HJ, Cooke GS, van Helden PD, Hoal EG. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet. 2003;361: 1871–1872. pmid:12788577 doi: 10.1016/s0140-6736(03)13491-5
[15]
Hoal EG, Lewis L-A, Jamieson SE, Tanzer F, Rossouw M, Victor T, et al. SLC11A1 (NRAMP1) but not SLC11A2 (NRAMP2) polymorphisms are associated with susceptibility to tuberculosis in a high-incidence community in South Africa. Int J Tuberc Lung Dis. 2004;8: 1464–1471. pmid:15636493
[16]
M？ller M, Flachsbart F, Till A, Thye T, Horstmann RD, Meyer CG, et al. A functional haplotype in the 30UTR of TNFRSF1B is associated with TB in two African populations. Am J Respir Crit Care Med. 2010;181: 388–393. doi: 10.1164/rccm.200905-0678OC. pmid:20007930
[17]
Fortin A, Abel L, Casanova JL, Gros P. Host genetics of mycobacterial diseases in mice and men: forward genetic studies of BCG-osis and tuberculosis. Ann Rev Genomics Hum Genet. 2007; 8: 163–192. doi: 10.1146/annurev.genom.8.080706.092315
[18]
Abel L, El-Baghdadi J, Bousfiha AA, Casanova JL, Schurr E. Human genetics of tuberculosis: a long and winding road. Philos Trans R Soc Lond B Biol Sci. 2014. 12; 369(1645): 20130428. doi: 10.1098/rstb.2013.0428. pmid:24821915
[19]
Schurr E, Kramnik I. Genetic Control of Host Susceptibility to Tuberculosis. In: Kaufmann SH, Britton WJ, editors. Handbook of Tuberculosis: Immunology and Cell Biology. 2008. pp. 295–336.
[20]
Apt AS. Are mouse models of human mycobacterial diseases relevant? Genetics says: 'yes!'. Immunology. 2011;134: 109–115. doi: 10.1111/j.1365-2567.2011.03472.x. pmid:21896006
[21]
Yan BS, Kirby A, Shebzukhov YV, Daly MJ, Kramnik I. Genetic architecture of tuberculosis resistance in a mouse model of infection. Genes Immun. 2006;7: 201–210. pmid:16452998 doi: 10.1038/sj.gene.6364288
[22]
Sanchez F, Radaeva TV, Nikonenko BV, Persson A, Sengul S, Schalling M, et al. Multigenic control of disease severity after Mycobacterium tuberculosis infection in mice. Infect. Immun. 2003; 71: 126–131. pmid:12496157 doi: 10.1128/iai.71.1.126-131.2003
[23]
Lavebratt C, Apt AS, Nikonenko BV, Schalling M, Schurr E. Severity of tuberculosis in mice is linked to distal chromosome 3 and proximal chromosome 9. J Inf Dis. 1999;180: 150–155. doi: 10.1086/314843
[24]
Mitsos LM, Cardon LR, Fortin A, Ryan L, LaCourse R, North R, et al. Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. Genes Immun. 2000; 1: 467–477. pmid:11197687 doi: 10.1038/sj.gene.6363712
[25]
Mitsos LM, Cardon LR, Ryan L, LaCourse R, North RJ, Gros P. Susceptibility to tuberculosis: A locus on mouse chromosome 19 (Trl4) regulates Mycobacterium tuberculosis replication in the lungs. Proc Natl Acad Sci USA. 2003; 100: 6610–6615. pmid:12740444 doi: 10.1073/pnas.1031727100
[26]
Nikonenko BV, Averbakh MM, Lavebratt C, Schurr E, Apt AS. Comparative analysis of mycobacterial infections in susceptible I/St and resistant A/Sn inbred mice. Tubercle Lung Dis. 2000; 80: 15–25. doi: 10.1054/tuld.1999.0225
[27]
Mehra NK. Role of HLA linked factors in governing susceptibility to leprosy and tuberculosis. Tropical Med Parasitol. 1990; 41: 352–354.
[28]
Goldfeld A, Delgado JC, Thim S, Bozon MV, Uglialoro AM, Turbay D, et al. Association of an HLA-DQ allele with clinical tuberculosis. J Am Med Assoc. 1998; 279: 226–228.
[29]
Hoal EG. Human genetic susceptibility to tuberculosis and other mycobacterial diseases. IUBMB Life. 2002; 53: 225–229. pmid:12121000 doi: 10.1080/15216540212644
[30]
M？ller M, de Wit E, Hoal EG. Past, present and future directions in human genetic susceptibility to tuberculosis. FEMS Immunol Med Microbiol 2010;58: 3–26. doi: 10.1111/j.1574-695X.2009.00600.x. pmid:19780822
[31]
Apt AS, Avdienko VG, Nikonenko BV, Kramnik IB, Moroz AM, Skamene E. Distinct H-2 complex control of mortality and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice. Clin. Exp. Immunol. 1993; 94: 322–331. pmid:8222323 doi: 10.1111/j.1365-2249.1993.tb03451.x
[32]
Medina E, North RJ. Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype. Immunology 1998;93: 270–274. pmid:9616378 doi: 10.1046/j.1365-2567.1998.00419.x
[33]
Pichugin AV, Petrovskaya SN, Apt AS. H2 complex controls СD4/CD8 ratio, recurrent responsiveness to repeated stimulations, and resistance to activation-induced apoptosis during T cell response to mycobacterial antigens. J Leuk Biol. 2006;79: 739–46. doi: 10.1189/jlb.0705392
[34]
Beamer GL, Cyktor J, Carruthers B, Turner J. H-2 alleles contribute to Antigen 85-specific interferon-gamma responses during Mycobacterium tuberculosis infection. Cell Immunol. 2011; 271(1): 53–61. doi: 10.1016/j.cellimm.2011.06.002. pmid:21714962
[35]
Chackerian AA, Behar SM. Susceptibility to Mycobacterium tuberculosis: lessons from inbred strains of mice. Tuberculosis (Edinb). 2003; 83(5): 279–85. doi: 10.1016/s1472-9792(03)00017-9
[36]
Asherson GL, Dieli F, Gautam Y, Siew LK, Zembala M. Major histocompatibility complex regulation of the class of the immune response: the H-2d haplotype determines poor interferon-gamma response to several antigens. Eur J Immunol. 1990; 20: 1305–1310. pmid:2114997 doi: 10.1002/eji.1830200616
[37]
Kamath AB, Alt J, Debbabi H, Taylor C, Behar SM. The major histocompatibility complex haplotype affects T-cell recognition of mycobacterial antigens but not resistance to Mycobacterium tuberculosis in C3H mice. Infect Immun 2004;72: 6790–6798. pmid:15557599 doi: 10.1128/iai.72.12.6790-6798.2004
[38]
Brett S, Orrell JM, Swanson Beck J, Ivanyi J. Influence of H-2 genes on growth of Mycobacterium tuberculosis in the lungs of chronically infected mice. Immunology 1992; 76: 129–132. pmid:1628890
[39]
Brett SJ, Ivanyi J. Genetic influences on the immune repertoire following tuberculous infection in mice. Immunology 1990; 71: 113–119. pmid:2120127
[40]
Flint J, Valdar W, Shifman S, Mott R. Strategies for mapping and cloning quantitative trait genes in rodents. Nat Rev Genet. 2005; 6: 271–286. pmid:15803197 doi: 10.1038/nrg1576
[41]
Sollid LM, Pos W, Wucherpfennig KW. Molecular mechanisms for contribution of MHC molecules to autoimmune diseases.Curr Opin Immunol. 2014;31: 24–30. doi: 10.1016/j.coi.2014.08.005. pmid:25216261
[42]
Vandiedonck C, Knight JC. The human Major Histocompatibility Complex as a paradigm in genomics research. Brief Funct Genomic Proteomic. 2009; 8: 379–394. doi: 10.1093/bfgp/elp010. pmid:19468039
[43]
Ahmad T, Neville M, Marshall SE, Armuzzi A, Mulcahy-Hawes K, Crawshaw J, et al. Haplotype-specific linkage disequilibrium patterns define the genetic topography of the human MHC. Hum Mol Genet. 2003; 12: 647–656. pmid:12620970 doi: 10.1093/hmg/ddg066
[44]
Horton R, Wilming L, Rand V, Lovering RC, Bruford EA, Khodiyar VK, et al. Gene map of extended human MHC. Nat Rev Genet.2004; 5: 889–899. pmid:15573121 doi: 10.1038/nrg1489
[45]
Korotetskaia MV, Kapina MA, Averbakh MM, Evstifeev VV, Apt AS, Logunova NN. A locus involved in tuberculosis infection control in mice locates in the proximal part of the H2 complex. Mol Biol (Mosk). 2011; 45(1): 68–76. Russian. doi: 10.1134/s0026893311010067
[46]
Radaeva TV, Kondratieva EV, Sosunov VV, Majorov KB, Apt A. A human-like TB in genetically susceptible mice followed by the true dormancy in a Cornell-like model. Tuberculosis (Edinb). 2008; 88: 576–85. doi: 10.1016/j.tube.2008.05.003
[47]
Kondratieva EV, Logunova NN, Majorov KB, Averbakh MM, Apt AS. Host genetics in granuloma formation: human-like lung pathology in mice with reciprocal genetic susceptibility to Mycobacterium tuberculosis and M. avium. PLoS ONE. 2010; 6: e10515. doi: 10.1371/journal.pone.0010515
[48]
Cooper AM. Cell-mediated immune responses in tuberculosis. Ann Rev Immunol. 2009; 27: 393–422. doi: 10.1146/annurev.immunol.021908.132703
[49]
Kapina MA, Rubakova EI, Majorov KB, Logunova NN, Apt AS. Capacity of lung stroma to educate dendritic cells inhibiting mycobacteria-specific T-cell response depends upon genetic susceptibility to tuberculosis. PLoS One. 2013; 15(8):e72773. doi: 10.1371/journal.pone.0072773
[50]
McBeth C, Seamons A, Pizarro JC, Fleishman SJ, Baker D, Kortemme T, et al. A new twist in TCR diversity revealed by a forbidden alpha beta TCR. J Mol Biol. 2008; 375: 1306–1319. pmid:18155234 doi: 10.1016/j.jmb.2007.11.020
[51]
Painter CA, Stern LJ. Conformational variation in structures of classical and non-classical MHCII proteins and functional implications. Immunol Rev. 2012; 250 (1):144–57. doi: 10.1111/imr.12003. pmid:23046127
[52]
Scott CA, Peterson PA, Teyton L, Wilson IA. Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity. 1998; 8 (3):319–29. pmid:9529149 doi: 10.1016/s1074-7613(00)80537-3
[53]
Zhu Y, Rudensky AY, Corper AL, Teyton L, Wilson IA. Crystal structure of MHC Class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide binding motif. J Mol Biol. 2003; 326: 1157–1174. pmid:12589760 doi: 10.1016/s0022-2836(02)01437-7
[54]
Roberts LJ, Baldwin TM, Curtis JM, Handman E, Foote SJ. Resistance to Leishmania major is linked to the H2 region on chromosome 17 and to chromosome 9. J Exp Med. 1997; 185: 1705–1710. pmid:9151907 doi: 10.1084/jem.185.9.1705
[55]
Burt RA, Baldwin TM, Marshall VM, Foote SJ. Temporal expression of an H2-linked locus in host response to mouse malaria. Immunogenetics. 1999; 50: 278–285. pmid:10630291 doi: 10.1007/s002510050603
[56]
Goncalves LA, Almedia P, Mota MM, Penha-Goncales C. Malaria liver stage susceptibility locus identified on mouse chromosome 17 by congenic mapping. PLoS ONE. 2008;3 (3): e1874. doi: 10.1371/journal.pone.0001874. pmid:18365019
[57]
Goodhead I, Archibald A, Amwayi P, Brass A, Gibson J, Hall N, et al. A comprehensive genetic analysis of candidate genes regulating response to Trypanosoma congolense infection in mice. PLoS Negl Trop Dis. 2010; 4 (11): e880. doi: 10.1371/journal.pntd.0000880. pmid:21085469
[58]
Smith PM, Shainheit MG, Bazzone LE, Rutitzky LI, Poltorak A, Stadecker MJ. Genetic control of severe egg-induced immunopathology and IL-17 production in murine schistosomiasis. J Immunol. 2009; 183 (5): 3317–3323. doi: 10.4049/jimmunol.0901504. pmid:19675160
[59]
Melino MR, Epstein SL, Sachs DH, Hansen TH. Idiotypic and fluorometric analysis of the antibodies that distinguish the lesion of the I-A mutant B6.C-H-2bm12. J Immunol. 1983; 131(1):359–64. pmid:6190915
[60]
Ronchese F, Brown MA, Germain RN. Structure-function analysis of the Abm12 beta mutation using site-directed mutagenesis and DNA-mediated gene transfer. J Immunol. 1987;139(2): 629–38. pmid:3110276
[61]
Snell GD. Methods for the study of histocompatibility genes. J. Genet. 1948. 49, 87–108. pmid:18893744 doi: 10.1007/bf02986826
[62]
Pichugin AV, Khaidukov SV, Moroz AM, Apt AS. Capacity of murine T cells to retain long-term responsiveness to mycobacterial antigens is controlled by the H-2 complex Clin Exp Immunol. 1998; 111(2): 316–324. pmid:9486398 doi: 10.1046/j.1365-2249.1998.00498.x
[63]
Majorov KB, Lyadova IV, Kondratieva TK, Eruslanov EB, Rubakova EI, Orlova MO, Mischenko VV, Apt AS. Different innate ability of I/St and A/Sn mice to combat virulent M. tuberculosis: phenotypes expressed in lung and extra-pulmonary macrophages. Infect. Immun. 2003; 71(2):697–707. pmid:12540548 doi: 10.1128/iai.71.2.697-707.2003
[64]
Eruslanov EB, Majorov KB, Orlova MO, Mischenko VV, Kondratieva TK, Apt AS, et al. Lung cell responses to M. tuberculosis in genetically susceptible and resistant mice following intratracheal challenge. Clin Exp Immunol. 2004; 135(1): 19–28. pmid:14678260 doi: 10.1111/j.1365-2249.2004.02328.x
